VANCOUVER, British Columbia, May 19, 2011 /PRNewswire/ -- Abattis Biologix Corporation ("Abattis") (CNSX: FLU) engaged the services of a well-known natural food and products expert to develop new business opportunities and conduct multi-faceted media campaigns for its Immune Solutions™ line of proprietary products. The products address a range of biological and environment-induced reactions that compromise immunity. Margie Adelman, principle, of Adelman PR Inc. will start on the projects effective immediately.
Abattis Chief Executive Officer Mike Withrow says, "Margie brings a high level of professionalism to Abattis, and with more than 20 years in the natural food and nutritional supplement industry, she brings a true depth of knowledge. She will further fortify the bench strength of the exceptional management team we have assembled for the execution of our strategic plans. We will utilize her vast experience in launching the Immune Solutions product line, developing strategic partnerships and joint ventures, positioning our brand, and implementing socially responsible programs for malnourished people around the world."
"I am enthusiastic about bringing the APR network to the Abattis management team, and I look forward to leveraging my business development experience and industry and media contacts to launch Immune Solutions, the next generation of scientifically advanced natural health products. They are outstanding products that can become category leaders," says Adelman.
The company recently announced the appointment of Tim Fealey to the Board of Directors whose former posts include executive roles at Coca Cola, Proctor & Gamble and Martek Biosciences. Mr. Fealey has also been engaged as an independent consultant and is a partner in OTC Nutrition, which Abattis has issued a Letter of Intent to acquire certain proprietary delivery technologies and formulas. Additionally, Abattis has engaged Dr. Samuel Brant, who has a rich history spanning over two decades of product development for major nutraceutical companies, as a consultant and has acquired three of his proprietary formulas that will be marketed through Abattis as the next generation of flu treatment and prevention OTC products.
For more information about Ms. Adelman go to www.abattis.com
About Abattis Biologix Corp.
Abattis Biologix Corporation is committed to the research, development and marketing of proprietary, natural health and wellness solutions that address chronic illnesses through targeted nutritional support. We manufacture and market the most scientifically advanced natural therapeutic formulas based on proprietary technologies through multiple distribution channels, while providing the highest level of customer service.
Web: www.abattis.com Twitter: @abattis
Media Contact:Margie Adelman 916 220 3500Madelman @adelmanpr.com
SOURCE Abattis Biologix Corporation
Advertisement
Abattis Chief Executive Officer Mike Withrow says, "Margie brings a high level of professionalism to Abattis, and with more than 20 years in the natural food and nutritional supplement industry, she brings a true depth of knowledge. She will further fortify the bench strength of the exceptional management team we have assembled for the execution of our strategic plans. We will utilize her vast experience in launching the Immune Solutions product line, developing strategic partnerships and joint ventures, positioning our brand, and implementing socially responsible programs for malnourished people around the world."
Advertisement
"I am enthusiastic about bringing the APR network to the Abattis management team, and I look forward to leveraging my business development experience and industry and media contacts to launch Immune Solutions, the next generation of scientifically advanced natural health products. They are outstanding products that can become category leaders," says Adelman.
The company recently announced the appointment of Tim Fealey to the Board of Directors whose former posts include executive roles at Coca Cola, Proctor & Gamble and Martek Biosciences. Mr. Fealey has also been engaged as an independent consultant and is a partner in OTC Nutrition, which Abattis has issued a Letter of Intent to acquire certain proprietary delivery technologies and formulas. Additionally, Abattis has engaged Dr. Samuel Brant, who has a rich history spanning over two decades of product development for major nutraceutical companies, as a consultant and has acquired three of his proprietary formulas that will be marketed through Abattis as the next generation of flu treatment and prevention OTC products.
For more information about Ms. Adelman go to www.abattis.com
About Abattis Biologix Corp.
Abattis Biologix Corporation is committed to the research, development and marketing of proprietary, natural health and wellness solutions that address chronic illnesses through targeted nutritional support. We manufacture and market the most scientifically advanced natural therapeutic formulas based on proprietary technologies through multiple distribution channels, while providing the highest level of customer service.
Web: www.abattis.com Twitter: @abattis
Media Contact:Margie Adelman 916 220 3500Madelman @adelmanpr.com
SOURCE Abattis Biologix Corporation
